CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- 4 Grant or award Director acquired 164,745 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 41,186 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 824 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Results of operations · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 8-K Event Auditor change
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Gift President and CEO gave 3,000 shares (gift)
Page 8 of 16 · 315 filings